A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre

NARecruitingINTERVENTIONAL
Enrollment

936

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2026

Conditions
Solid TumorMetastatic Cancer
Interventions
DIAGNOSTIC_TEST

Comprehensive genomic profiling

TSO500 (523 genes + MTB + MSI)

Trial Locations (12)

1090

NOT_YET_RECRUITING

AZ VUB, Brussels

2020

NOT_YET_RECRUITING

ZNA, Antwerp

2610

RECRUITING

GZA, Antwerp

2650

RECRUITING

Universitaire Ziekenhuis Antwerpen, Edegem

3000

NOT_YET_RECRUITING

UZ Leuven, Leuven

3500

RECRUITING

Jessa Ziekenhuis, Hasselt

6000

NOT_YET_RECRUITING

Grand Hôpital de Charleroi, Charleroi

9000

NOT_YET_RECRUITING

UZ Gent, Ghent

Unknown

NOT_YET_RECRUITING

ASZ Aalst, Aalst

RECRUITING

AZ Sint-Jan, Bruges

RECRUITING

AZ Delta, Roeselare

RECRUITING

AZ Turnhout, Turnhout

Sponsors
All Listed Sponsors
collaborator

Illumina, Inc.

INDUSTRY

collaborator

OncoDNA

INDUSTRY

collaborator

PierianDx

UNKNOWN

lead

The Belgian Society of Medical Oncology

OTHER